West Paces Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.4K Hold
25
– – ﹤0.01% 611
2026
Q2
$700 Buy
+25
New +$703 ﹤0.01% 684
2025
Q2
– Sell
-25
Closed -$807 – 227
2025
Q1
$807 Hold
25
– – ﹤0.01% 507
2024
Q4
$764 Hold
25
– – ﹤0.01% 505
2024
Q3
$701 Hold
25
– – ﹤0.01% 499
2024
Q2
$569 Hold
25
– – ﹤0.01% 525
2024
Q1
$761 Hold
25
– – ﹤0.01% 529
2023
Q4
$892 Hold
25
– – ﹤0.01% 516
2023
Q3
$1.1K Hold
25
– – ﹤0.01% 460
2023
Q2
$1.23K Hold
25
– – ﹤0.01% 483
2023
Q1
$1.04K Hold
25
– – ﹤0.01% 507
2022
Q4
$1.11K Hold
25
– – ﹤0.01% 468
2022
Q3
$978 Hold
25
– – ﹤0.01% 469
2022
Q2
$1.02K Hold
25
– – ﹤0.01% 520
2022
Q1
$1.64K Hold
25
– – ﹤0.01% 495
2021
Q4
$1.74K Hold
25
– – ﹤0.01% 528
2021
Q3
$1.74K Hold
25
– – ﹤0.01% 525
2021
Q2
$1.98K Hold
25
– – ﹤0.01% 541
2021
Q1
$1.64K Hold
25
– – ﹤0.01% 417
2020
Q4
$1.39K Hold
25
– – ﹤0.01% 401
2020
Q3
$998 Buy
+25
New +$1.06K ﹤0.01% 402

Other funds holding ATRC

West Paces Advisors's ATRC Position: Q3 2026 in Review

West Paces Advisors held its AtriCure (ATRC) position steady in Q3 2026 at 25 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

West Paces Advisors first reported a position in ATRC in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.98K in Q2 2021. 80 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • West Paces Advisors held 25 shares of AtriCure worth $1.4K as of Q3 2026.
  • West Paces Advisors left its AtriCure share count unchanged in Q3 2026.
  • AtriCure made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #611 holding.
  • West Paces Advisors first reported a position in AtriCure in Q3 2020 and has held it in 21 quarters since.
  • West Paces Advisors's AtriCure position peaked at $1.98K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.